Mr. Kyle A. Lefkoff is an Independent Chairman of the Board of Array Biopharma Inc. From January 2012 through April 2012, Mr. Lefkoff served as our interim Executive Chairman following the resignation of our former Chief Executive …
Array BioPharma Inc. ARRY was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading …
The stock has gained 18.05% over the past three months and 87.54 ... Register for your free report coverage on ARRY at: Shares in Victoria, Canada headquartered Aurinia Pharmaceuticals Inc. ended the day 0.80% higher at $6.28. A total …
Array BioPharma Inc. (ARRY) announced after the bell Wednesday that it has commenced an underwritten public offering of $175,000,000 of shares of its common stock. The stock is now down 0.76 on 221K shares. Array BioPharma posted …
The stock has risen 96 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARRY …
Yahoo!1mon
New York headquartered Intra-Cellular Therapies Inc.’s stock finished Tuesday’s session 0.77% higher at $20.93 with a total trading volume of 244,492 shares. The stock has gained 18.05% over the past three months and 87.54% in the …
New York headquartered Intra-Cellular Therapies Inc.’s stock finished Tuesday’s session 0.77% higher at $20.93 with a total trading volume of 244,492 shares. The stock has gained 18.05% over the past three months and 87.54% in the …
Array BioPharma Inc. ARRY was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the …
The stock has risen 96 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARRY …